The official journal of the Brazilian Diabetes Society.
Response to semaglutide of non-drinker subjects with type 2 diabetes
Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) displays a worse prognosis in subjects with type 2 diabetes (T2D); effective treatments are, so far, scanty. Semaglutide showed efficacy in impr...